324 related articles for article (PubMed ID: 22777943)
21. Clinical value of autoantibodies against C1q in children with glomerulonephritis.
Kozyro I; Perahud I; Sadallah S; Sukalo A; Titov L; Schifferli J; Trendelenburg M
Pediatrics; 2006 May; 117(5):1663-8. PubMed ID: 16651321
[TBL] [Abstract][Full Text] [Related]
22. Anti-dsDNA, anti-nucleosome and anti-C1q antibodies as disease activity markers in patients with systemic lupus erythematosus.
Zivković V; Stanković A; Cvetković T; Mitić B; Kostić S; Nedović J; Stamenković B
Srp Arh Celok Lek; 2014; 142(7-8):431-6. PubMed ID: 25233687
[TBL] [Abstract][Full Text] [Related]
23. C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis.
Sjöwall C; Olin AI; Skogh T; Wetterö J; Mörgelin M; Nived O; Sturfelt G; Bengtsson AA
Autoimmunity; 2013 May; 46(3):205-14. PubMed ID: 23331132
[TBL] [Abstract][Full Text] [Related]
24. [Is autoantibody determination in patients with systemic lupus erythematosus useful? Anti-C1q-autoantibody as an example].
Trendelenburg M; Schifferli JA
Praxis (Bern 1994); 1998 Dec; 87(51-52):1811-3. PubMed ID: 10025155
[TBL] [Abstract][Full Text] [Related]
25. Measurement of autoantibodies in pediatric-onset systemic lupus erythematosus and their relationship with disease-associated manifestations.
Gilliam BE; Ombrello AK; Burlingame RW; Pepmueller PH; Moore TL
Semin Arthritis Rheum; 2012 Jun; 41(6):840-8. PubMed ID: 22177108
[TBL] [Abstract][Full Text] [Related]
26. High frequency of concurrent anti-C1q and anti-dsDNA but not anti-C3b antibodies in patients with Lupus Nephritis.
Kianmehr N; Khoshmirsafa M; Shekarabi M; Falak R; Haghighi A; Masoodian M; Seif F; Omidi F; Shirani F; Dadfar N
J Immunoassay Immunochem; 2021 Jul; 42(4):406-423. PubMed ID: 33788670
[TBL] [Abstract][Full Text] [Related]
27. Lupus nephritis sera contain autoantibodies that recognize epitopes within the globular fragment of C1q.
Deliyska B; Tsacheva I; Radanova M; Stoianova V; Tchorbadjieva M; Dobreva N
Med Pregl; 2007; 60 Suppl 2():25-7. PubMed ID: 18928152
[TBL] [Abstract][Full Text] [Related]
28. Do circulating antibodies against C1q reflect the activity of lupus nephritis?
Smykał-Jankowiak K; Niemir ZI; Polcyn-Adamczak M
Pol Arch Med Wewn; 2011 Sep; 121(9):287-95. PubMed ID: 21860370
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic and prognostic significance of anti-C1q antibodies in systemic lupus erythematosus.
Seelen MA; Trouw LA; Daha MR
Curr Opin Nephrol Hypertens; 2003 Nov; 12(6):619-24. PubMed ID: 14564199
[TBL] [Abstract][Full Text] [Related]
30. Anti-C1q antibodies in lupus nephritis and their correlation with the disease activity.
Emad G; Al-Barshomy SM
Saudi J Kidney Dis Transpl; 2020; 31(2):342-352. PubMed ID: 32394906
[TBL] [Abstract][Full Text] [Related]
31. Anti-C1q autoantibodies do not correlate with the occurrence or severity of experimental lupus nephritis.
Bigler C; Hopfer H; Danner D; Schaller M; Mihatsch MJ; Trendelenburg M
Nephrol Dial Transplant; 2011 Apr; 26(4):1220-8. PubMed ID: 20841491
[TBL] [Abstract][Full Text] [Related]
32. Anti C1q antibodies in cutaneous lupus erythematosus.
Bălănescu E; Tănăsescu C; Bălănescu P; Olteanu R; Badea C; Petruţescu B; Grancea C; Vagu C; Bleotu C; Ruţă S; Ardeleanu C
Rom J Intern Med; 2010; 48(2):159-63. PubMed ID: 21428180
[TBL] [Abstract][Full Text] [Related]
33. Anti-C1q antibodies are associated with systemic lupus erythematosus disease activity and lupus nephritis in northeast of China.
Zhang CQ; Ren L; Gao F; Mu FY; You YQ; Liu YH
Clin Rheumatol; 2011 Jul; 30(7):967-73. PubMed ID: 21340499
[TBL] [Abstract][Full Text] [Related]
34. Antibodies against C1q Are a Valuable Serological Marker for Identification of Systemic Lupus Erythematosus Patients with Active Lupus Nephritis.
Chi S; Yu Y; Shi J; Zhang Y; Yang J; Yang L; Liu X
Dis Markers; 2015; 2015():450351. PubMed ID: 26549923
[TBL] [Abstract][Full Text] [Related]
35. Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus.
Mok CC; Ho LY; Leung HW; Wong LG
Transl Res; 2010 Dec; 156(6):320-5. PubMed ID: 21078493
[TBL] [Abstract][Full Text] [Related]
36. Combination of anti-C1q and anti-dsDNA antibodies is associated with higher renal disease activity and predicts renal prognosis of patients with lupus nephritis.
Yang XW; Tan Y; Yu F; Zhao MH
Nephrol Dial Transplant; 2012 Sep; 27(9):3552-9. PubMed ID: 22700716
[TBL] [Abstract][Full Text] [Related]
37. Anti-C1q autoantibodies as markers of renal involvement in childhood-onset systemic lupus erythematosus.
Picard C; Lega JC; Ranchin B; Cochat P; Cabrera N; Fabien N; Belot A
Pediatr Nephrol; 2017 Sep; 32(9):1537-1545. PubMed ID: 28343355
[TBL] [Abstract][Full Text] [Related]
38. Pathogenic role of anti-C1q autoantibodies in the development of lupus nephritis--a hypothesis.
Flierman R; Daha MR
Mol Immunol; 2007 Jan; 44(1-3):133-8. PubMed ID: 16870257
[TBL] [Abstract][Full Text] [Related]
39. Cut-off values of immunological tests to identify patients at high risk of severe lupus nephritis.
Gargiulo MLÁ; Khoury M; Gómez G; Grimaudo S; Suárez L; Collado MV; Sarano J
Medicina (B Aires); 2018; 78(5):329-335. PubMed ID: 30285925
[TBL] [Abstract][Full Text] [Related]
40. Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers.
Akhter E; Burlingame RW; Seaman AL; Magder L; Petri M
Lupus; 2011 Oct; 20(12):1267-74. PubMed ID: 21813587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
